Sophia Paspal

Nessuna posizione attualmente

Health Technology

Consumer Services

Profilo

Sophia Paspal worked as a Director of Regulatory Affairs & Oncology at Halozyme Therapeutics, Inc. from 2015 to 2017.
Prior to that, she was an Associate Director of Regulatory Affairs & Neurology at Dart NeuroScience LLC in 2014-2015.
Dr. Paspal also served as the Chief Development Officer at Xynomic Pharmaceuticals Holdings, Inc. Dr. Paspal received her undergraduate and doctorate degrees from the University of Minnesota.

Precedenti posizioni note di Sophia Paspal

Società	Posizione	Fine
HALOZYME THERAPEUTICS, INC.	Corporate Officer/Principal	01/01/2017
Dart NeuroScience LLC Dart NeuroScience LLC Pharmaceuticals: MajorHealth Technology Develops drugs to improve memory	Corporate Officer/Principal	01/01/2015
XYNOMIC PHARMACEUTICALS HOLDINGS, INC.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Sophia Paspal

Formazione di Sophia Paspal

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Sophia Paspal

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
Halozyme Therapeutics, Inc. Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets	Health Technology
University of Minnesota University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Dart NeuroScience LLC Dart NeuroScience LLC Pharmaceuticals: MajorHealth Technology Develops drugs to improve memory	Health Technology
Xynomic Pharmaceuticals Holdings, Inc. Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and supplies oncology drugs	Health Technology